Rituximab Is Preferable to Cyclophosphamide for Treatment of Membranous Nephropathy: PRO
Néstor Oliva-Dámaso, Andrew S. Bomback
Abstract
This is an Early Access article. Please select the PDF button, above, to view it. Be sure to also read the CON: 10.34067/KID.0001432021 and the COMMENTARY: 10.34067/KID.0002492021
Topics & Concepts
RituximabCyclophosphamideMedicineMembranous nephropathyImmunologyNephropathyAntibodyInternal medicineGlomerulonephritisChemotherapyKidneyEndocrinologyDiabetes mellitusRenal Diseases and GlomerulopathiesChronic Kidney Disease and DiabetesSystemic Sclerosis and Related Diseases